PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Azelastine hydrochloride - Allergic rhinitis
PAD Profile : Azelastine hydrochloride - Allergic rhinitis
Keywords :
Hay fever, hayfever, antihistamines, nasal sprays, allergy, seasonal allergic rhinitis, intranasal antihistamines, pollen allergy, non-sedating antihistamines
Brand Names Include :
Rhinolast, Aller-eze, Azelair
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Fluticasone furoate
- Cetirizine hydrochloride
- Loratadine
- Triamcinolone acetonide
- Beclometasone dipropionate
- Desloratadine
- Levocetirizine
- Budesonide
- Mometasone furoate
- Ipratropium bromide
- Bilastine
- Mizolastine
- Acrivastine
- Fexofenadine hydrochloride
- Rupatadine fumarate
- House dust mites allergen extract
- White Birch pollen allergen extract
- Mometasone furoate/olopatadine hydrochloride
- Chlorphenamine maleate
- Ketotifen fumarate
- Promethazine hydrochloride
- Fluticasone propionate (Nasal)
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Azelastine is the only intranasal antihistamine that is licensed in the UK for the treatment of allergic rhinitis.
It was agreed as a treatment option for intermittent mild symptoms where it has a fast onset of action.
See local guidelines below
Associated BNF Codes
12. Ear, Nose and Oropharynx
12.02.01. Drugs used in nasal allergy